Stevanato Group (NYSE:STVN) Shares Gap Down – What’s Next?

Stevanato Group S.p.A. (NYSE:STVN)’s stock price gapped down prior to trading on Friday. The stock had previously closed at €20.98, but opened at €20.07. Stevanato Group shares last traded at €20.31, with a volume of 2,157 shares trading hands.

Analyst Ratings Changes

Several analysts have issued reports on STVN shares. TD Cowen raised shares of Stevanato Group to a “strong-buy” rating in a research note on Wednesday, June 17th. Weiss Ratings upgraded Stevanato Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, August 27th. Finally, UBS Group initiated coverage on Stevanato Group in a research report on Wednesday, September 9th. They set a “neutral” rating and a $23.00 price target on the stock. Two analysts have rated the stock with a Strong Buy rating, two have given a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy”.

Stevanato Group Price Performance

The company has a quick ratio of 1.08, a current ratio of 1.61 and a debt-to-equity ratio of 0.21. The stock’s 50 day moving average price is €21.10 and its two-hundred day moving average price is €18.45. The firm has a market capitalization of $6.14 billion, a price-to-earnings ratio of 36.20, a P/E/G ratio of 1.71 and a beta of 0.78.

Stevanato Group (NYSE:STVN) last issued its earnings results on Wednesday, August 5th. The company reported €0.14 EPS for the quarter, missing analysts’ consensus estimates of €0.15 by (€0.01). Stevanato Group had a net margin of 10.99% and a return on equity of 10.43%. The firm had revenue of €302.00 million during the quarter. Analysts anticipate that Stevanato Group S.p.A. will post 0.69 EPS for the current fiscal year.

Insider Transactions at Stevanato Group

In other Stevanato Group news, insider Mauro Stocchi sold 13,649 shares of Stevanato Group stock in a transaction that occurred on Monday, September 28th. The shares were sold at an average price of €21.50, for a total value of €293,453.50. Following the completion of the sale, the insider directly owned 400,000 shares in the company, valued at €8,600,000. The trade was a 3.30% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Elisabetta Magistretti sold 2,045 shares of the stock in a transaction on Friday, August 7th. The stock was sold at an average price of €20.09, for a total transaction of €41,084.05. Following the transaction, the director owned 2,930 shares in the company, valued at approximately €58,863.70. This trade represents a 41.11% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 21,926 shares of company stock worth $459,738. Corporate insiders own 0.70% of the company’s stock.

Institutional Trading of Stevanato Group

Several large investors have recently made changes to their positions in the stock. Integrated Wealth Concepts LLC bought a new position in shares of Stevanato Group in the 2nd quarter valued at approximately $59,000. Squarepoint Ops LLC grew its holdings in Stevanato Group by 131.2% during the second quarter. Squarepoint Ops LLC now owns 193,311 shares of the company’s stock valued at $3,493,000 after purchasing an additional 109,702 shares during the last quarter. Wellington Management Group LLP acquired a new position in Stevanato Group during the second quarter valued at approximately $22,621,000. Ranger Investment Management L.P. bought a new position in shares of Stevanato Group in the second quarter valued at approximately $21,438,000. Finally, Handelsbanken Fonder AB raised its position in shares of Stevanato Group by 26.4% in the second quarter. Handelsbanken Fonder AB now owns 30,600 shares of the company’s stock valued at $553,000 after purchasing an additional 6,400 shares during the period.

Stevanato Group Company Profile

Stevanato Group S.p.A. is an Italy-based provider of drug-containment, drug-delivery and diagnostic solutions for the pharmaceutical, biotechnology and healthcare industries. The company serves customers across the development, production and administration of injectable medicines, with activities spanning pharmaceutical glass packaging, medical devices and manufacturing technologies.

Its product portfolio includes glass vials, cartridges, syringes and other primary containers, as well as ready-to-use packaging solutions such as EZ-fill.